172 related articles for article (PubMed ID: 30439444)
1. Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification.
Paganini C; Monti L; Costantini R; Besio R; Lecci S; Biggiogera M; Tian K; Schwartz JM; Huber C; Cormier-Daire V; Gibson BG; Pirog KA; Forlino A; Rossi A
Matrix Biol; 2019 Aug; 81():70-90. PubMed ID: 30439444
[TBL] [Abstract][Full Text] [Related]
2. CANT1 deficiency in a mouse model of Desbuquois dysplasia impairs glycosaminoglycan synthesis and chondrocyte differentiation in growth plate cartilage.
Kodama K; Takahashi H; Oiji N; Nakano K; Okamura T; Niimi K; Takahashi E; Guo L; Ikegawa S; Furuichi T
FEBS Open Bio; 2020 Jun; 10(6):1096-1103. PubMed ID: 32277574
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic Characterization of Immortalized Chondrocytes from a Desbuquois Dysplasia Type 1 Mouse Model: A Tool for Studying Defects in Glycosaminoglycan Biosynthesis.
Gramegna Tota C; Valenti B; Forlino A; Rossi A; Paganini C
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502207
[TBL] [Abstract][Full Text] [Related]
4. Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis.
Nizon M; Huber C; De Leonardis F; Merrina R; Forlino A; Fradin M; Tuysuz B; Abu-Libdeh BY; Alanay Y; Albrecht B; Al-Gazali L; Basaran SY; Clayton-Smith J; Désir J; Gill H; Greally MT; Koparir E; van Maarle MC; MacKay S; Mortier G; Morton J; Sillence D; Vilain C; Young I; Zerres K; Le Merrer M; Munnich A; Le Goff C; Rossi A; Cormier-Daire V
Hum Mutat; 2012 Aug; 33(8):1261-6. PubMed ID: 22539336
[TBL] [Abstract][Full Text] [Related]
5. A novel homozygous variant in CANT1 in a patient with Kim-type Desbuquois dysplasia.
Menzies L; Cullup T; Calder A; Wilson L; Faravelli F
Clin Dysmorphol; 2019 Oct; 28(4):219-223. PubMed ID: 31348018
[No Abstract] [Full Text] [Related]
6. Prenatal diagnosis of Desbuquois dysplasia Type 1: Utilization of high-density SNP array to map homozygosity and identify the gene.
Forster KR; Hooper JE; Blakemore KJ; Baschat AA; Hoover-Fong J
Am J Med Genet A; 2019 Dec; 179(12):2490-2493. PubMed ID: 31587486
[TBL] [Abstract][Full Text] [Related]
7. A novel CANT1 mutation in three Indian patients with Desbuquois dysplasia Kim type.
Singh A; Kim OH; Iida A; Park WY; Ikegawa S; Kapoor S
Eur J Med Genet; 2015 Feb; 58(2):105-10. PubMed ID: 25486376
[TBL] [Abstract][Full Text] [Related]
8. CANT1 mutation is also responsible for Desbuquois dysplasia, type 2 and Kim variant.
Furuichi T; Dai J; Cho TJ; Sakazume S; Ikema M; Matsui Y; Baynam G; Nagai T; Miyake N; Matsumoto N; Ohashi H; Unger S; Superti-Furga A; Kim OH; Nishimura G; Ikegawa S
J Med Genet; 2011 Jan; 48(1):32-7. PubMed ID: 21037275
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of CANT1 gene variant in a girl with Desbuquois dysplasia type I].
Ma J; Yang Y; Zhang K; Huang Y; Lyu Y; Gao M; Gai Z; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Dec; 36(12):1206-1209. PubMed ID: 31813149
[TBL] [Abstract][Full Text] [Related]
10. A novel gene (FAM20B encoding glycosaminoglycan xylosylkinase) for neonatal short limb dysplasia resembling Desbuquois dysplasia.
Kuroda Y; Murakami H; Enomoto Y; Tsurusaki Y; Takahashi K; Mitsuzuka K; Ishimoto H; Nishimura G; Kurosawa K
Clin Genet; 2019 Jun; 95(6):713-717. PubMed ID: 30847897
[TBL] [Abstract][Full Text] [Related]
11. Mutations in Biosynthetic Enzymes for the Protein Linker Region of Chondroitin/Dermatan/Heparan Sulfate Cause Skeletal and Skin Dysplasias.
Mizumoto S; Yamada S; Sugahara K
Biomed Res Int; 2015; 2015():861752. PubMed ID: 26582078
[TBL] [Abstract][Full Text] [Related]
12. Desbuquois dysplasia type II in a patient with a homozygous mutation in XYLT1 and new unusual findings.
Silveira C; Leal GF; Cavalcanti DP
Am J Med Genet A; 2016 Nov; 170(11):3043-3047. PubMed ID: 27481334
[No Abstract] [Full Text] [Related]
13. Desbuquois dysplasia type I and fetal hydrops due to novel mutations in the CANT1 gene.
Laccone F; Schoner K; Krabichler B; Kluge B; Schwerdtfeger R; Schulze B; Zschocke J; Rehder H
Eur J Hum Genet; 2011 Nov; 19(11):1133-7. PubMed ID: 21654728
[TBL] [Abstract][Full Text] [Related]
14. XYLT1 mutations in Desbuquois dysplasia type 2.
Bui C; Huber C; Tuysuz B; Alanay Y; Bole-Feysot C; Leroy JG; Mortier G; Nitschke P; Munnich A; Cormier-Daire V
Am J Hum Genet; 2014 Mar; 94(3):405-14. PubMed ID: 24581741
[TBL] [Abstract][Full Text] [Related]
15. Desbuquois dysplasia Kim variant: a rare case report syndrome.
Agrawal N; Srivastava P; Phadke SR
Clin Dysmorphol; 2021 Jan; 30(1):62-65. PubMed ID: 33136656
[No Abstract] [Full Text] [Related]
16. Case of Desbuquois dysplasia type 1: potentially lethal skeletal dysplasia.
Inoue S; Ishii A; Shirotani G; Tsutsumi M; Ohta E; Nakamura M; Mori T; Inoue T; Nishimura G; Ogawa A; Hirose S
Pediatr Int; 2014 Aug; 56(4):e26-9. PubMed ID: 25252066
[TBL] [Abstract][Full Text] [Related]
17. Cartilage-Specific Autophagy Deficiency Promotes ER Stress and Impairs Chondrogenesis in PERK-ATF4-CHOP-Dependent Manner.
Kang X; Yang W; Feng D; Jin X; Ma Z; Qian Z; Xie T; Li H; Liu J; Wang R; Li F; Li D; Sun H; Wu S
J Bone Miner Res; 2017 Oct; 32(10):2128-2141. PubMed ID: 28304100
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycans.
Yoshida CA; Kawane T; Moriishi T; Purushothaman A; Miyazaki T; Komori H; Mori M; Qin X; Hashimoto A; Sugahara K; Yamana K; Takada K; Komori T
J Biol Chem; 2014 Sep; 289(38):26584-26596. PubMed ID: 25107907
[TBL] [Abstract][Full Text] [Related]
19. Cartilage-specific ablation of XBP1 signaling in mouse results in a chondrodysplasia characterized by reduced chondrocyte proliferation and delayed cartilage maturation and mineralization.
Cameron TL; Gresshoff IL; Bell KM; Piróg KA; Sampurno L; Hartley CL; Sanford EM; Wilson R; Ermann J; Boot-Handford RP; Glimcher LH; Briggs MD; Bateman JF
Osteoarthritis Cartilage; 2015 Apr; 23(4):661-70. PubMed ID: 25600960
[TBL] [Abstract][Full Text] [Related]
20. Pseudodiastrophic dysplasia expands the known phenotypic spectrum of defects in proteoglycan biosynthesis.
Byrne AB; Mizumoto S; Arts P; Yap P; Feng J; Schreiber AW; Babic M; King-Smith SL; Barnett CP; Moore L; Sugahara K; Mutlu-Albayrak H; Nishimura G; Liebelt JE; Yamada S; Savarirayan R; Scott HS
J Med Genet; 2020 Jul; 57(7):454-460. PubMed ID: 31988067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
